| Financial Year |
March 31 2023 |
| Monetary Funds |
2,804,864,463.77 |
| Held-for-trading Financial Assets |
476,071,426.18 |
| Notes Receivable |
26,982,475.80 |
| Accounts Receivable |
1,629,893,109.08 |
| Advances to Suppliers |
112,708,623.93 |
| Other Receivables |
414,550,589.12 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
2,220,528.79 |
| Dividend Receivable |
687,380.00 |
| Inventories |
415,735,800.02 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
18,879,421.20 |
| Other Current Assets |
116,765,381.70 |
| Total Current Assets |
7,363,690,384.92 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,377,164.45 |
| Long-term Equity Investment |
675,956,842.04 |
| Investment Properties |
-- |
| Fixed Assetes |
3,480,488,109.32 |
| Under-construction Projects |
132,079,140.96 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
513,139,661.08 |
| R&D expenses |
3,279,165.72 |
| Goodwill |
93,935,382.48 |
| Long-Term Deferred and Prepaid Expenses |
9,947,323.70 |
| Deferred Income Tax Assets |
55,605,059.06 |
| Other Non-Current Assets |
89,493,356.34 |
| Sub-Total of Non-Current Assets |
5,950,729,275.32 |
| Total Assets |
13,314,419,660.24 |
| Short-Term Loans |
863,839,255.23 |
| Trading Financial liabilities |
-- |
| Notes Payable |
104,536,552.47 |
| Accounts Payable |
1,715,586,624.60 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
27,988,588.97 |
| Taxes Payable |
59,448,126.24 |
| Interest Payable |
1,719,740.45 |
| Dividend Payable |
47,863,082.24 |
| Other payables |
256,593,746.62 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,493,982,813.89 |
| Other Current Liabilities |
5,928,952.15 |
| Sub-Total of Current Liabilities |
4,663,042,892.53 |
| Long-term Loans |
1,073,788,088.66 |
| Bonds Payable |
1,712,243,351.89 |
| Long-Term Accounts Payable |
3,397,348.58 |
| Special Payable |
-- |
| Estimatied Liabilities |
14,590,443.98 |
| Deferred Income Tax Liabilities |
3,488,623.31 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,819,126,727.45 |
| Total Liabilities |
7,482,169,619.98 |
| Paid-In Capital(Or Share Stock) |
920,887,108.00 |
| Capital Surplus |
1,165,119,500.56 |
| Surplus Reserve |
170,794,575.64 |
| LESS:Treasury Stock |
7,985,088.02 |
| Undistributed Profits |
1,225,026,368.03 |
| Minority Stockholder's Interest |
2,028,256,811.31 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,803,993,228.95 |
| Owner's Equity（Stockholder's Equity） |
5,832,250,040.26 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,314,419,660.24 |
